Director – Vaccines Value Evidence, Neisseria / Bacterial STI

工作内容

Site Name: Belgium-Wavre, GSK House, USA - Pennsylvania - Upper Providence

Posted Date: Oct 31 2022

Director – Vaccines Value Evidence, Neisseria / Bacterial STI

The role of Value Evidence Director is essential to ensuring that vaccines that GSK brings to market are supported by scientifically credible, high quality, evidence aligned with the needs of decision makers responsible for granting access / reimbursement. As important Value Evidence Department Team member you will be accountable to lead the global value evidence strategy and delivery for vaccines for selected strategic priorities/ streams within the Neisseria portfolio and selected vaccine targets in Sexually Transmitted Diseases (STIs) throughout the lifecycle of the assets in alignment with the Value Evidence [VE] accountabilities around the GSK integrated asset operating model, interacting and synergizing with wide range of internal and external stakeholders and their programmes, to inform relevant vaccine recommendation and reimbursement.

Key Responsibilities Include, But Are Not Limited To

• Lead and ensure alignment across the matrix organization for defined for defined strategic priorities/ streams within the Value Evidence Team for the Neisseria Portfolio and selected candidates in the STI field, drawn from VEO and other platforms (R&D as well as Commercial) to deliver the Value Evidence Generation strategic options, Value Evidence Plans and execution which fall under relevant integrated evidence plans: 
• Partner with the VEO Patient Centric Outcomes and VEO Real World Analytics teams to ensure the operational delivery of Patient Reported Outcomes (PROs), Real World Evidences (RWE), Epidemiology, Regions, VEO Operations as well as relevant Therapeutic Areas aligned with the Target vaccine Profile expectations and the lifecycle of the relevant asset. 
• Partner with relevant specific Neisseria and STI streams especially with related Value Evidence peers to ensure successful implementation and maximization for synergies and efficiency in study delivery. 
• Partner with a complex set of global, regional and key local internal stakeholders including Vaccine Development Leads, Global Vaccine Commercial Leads, Epidemiology and Clinical Scientists, global and local Medical Affairs, local Market Access, regional and key LOC contributors etc. and ensure appropriate representation at project governance level.  
• Lead the external dialogue on the global scientific Neisseria value evidence requirements for defined strategic priorities / streams (such as Neisseria gonorrhoea) as well as selected STIs in the covered portfolio, with recommendation and reimbursement bodies including seeking formal scientific advice to National Immunization Technical Advisory Committees (NITAGs) and Health Technology Assessment (HTA) bodies. 
• Responsible for the design and delivery of health outcomes strategies and studies for development and/or marketed compounds, including health economic studies, evidence syntheses, patient reported outcome development and implementation, burden of disease and real world effectiveness studies, run as part of or in parallel to development from Discovery through life cycle management. 
• Lead scientific robust value evidence studies in collaboration with direct report and broader VEO organization (e.g. cost-of-illness, resource utilization, utility and quality of life assessments, Patient Reported Outcomes (PROs), Real World Evidence (RWE), economic and public health impact modelling, indirect study comparisons, etc) ensuring scientific robustness and compliance with necessary regulations for quality and disclosure. 
• Lead annual budget forecasting and activity prioritization for defined streams while effectively managing projects and budgets for Human Subject Research (HSR) and non-HSR activities. 
• Lead potential vendors, agency workers allocated to the stream in ensuring successful implementation of respective Value Evidence Plans aligned to the overall Neisseria portfolio strategy. 
• Integrate excellent understanding of the evolving global NITAG, Health Technology Assessment, policy decision maker and payer environment, including recommendation, reimbursement, pricing, and access.
  

Why you?

Basic Qualifications

We are looking for professionals with these required skills to achieve our goals:

• Masters level or equivalent experience in health outcomes or relevant areas of specialisation
• Specific training / meaningful experience in at least 2 areas (health policy, reimbursement / access, health economics, modelling, patient reported outcomes, psychometrics, clinical trial design, observational research, epidemiology, statistics).
• Previous years experience in a health economist, market access or related function (consulting, pharmaceutical industry, academics), preferably including above country level experience
• Educational background with technical expertise consistent with scientific project planning, implementation, and delivery of evidence.
• Knowledge of global reimbursement processes / evidence requirements to inform access decisions. Experience of reimbursement / HTA submissions
• Proficient in managing multiple projects, budgets, and effectively navigate in matrix organisation interactions (internal / external consistent with each research project or activity).
• Experience in supervising team members, delegating tasks as well as providing supervision and development tailored to their capabilities and ambitions.
• Effective communicator (oral/written) who can translate specific research projects and outcomes, related complex material in presentations and discussions in a straightforward manner
• Good to excellent in computer skills: excel, word, powerpoint; experience in at least one modelling software and agility to further learn as relevant (for example Visual Basic, R)
• Authored publication
  

Preferred Qualifications

If you have the following characteristics, it would be a plus:

• PhD in a relevant discipline
• Launch or post marketing, market access experience in pharmaceutical or life science industry or related field
• Experience in infectious diseases, sexually transmitted diseases and/or vaccine health economics and outcomes research is considered as an asse
  

Why GSK?

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.

Find out more: Annual Report 2021

If you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK’s commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.